Gilead Sciences Earnings Estimate
| GILD Stock | USD 67.08 0.05 0.07% |
Gilead |
Gilead Sciences Earnings Estimation Breakdown
The calculation of Gilead Sciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Gilead Sciences is estimated to be -1.44 with the future projection ranging from a low of -1.74 to a high of -1.07. Please be aware that this consensus of annual earnings estimates for Gilead Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.74 Lowest | Expected EPS | -1.07 Highest |
Gilead Sciences Earnings Projection Consensus
Suppose the current estimates of Gilead Sciences' value are higher than the current market price of the Gilead Sciences stock. In this case, investors may conclude that Gilead Sciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Gilead Sciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2024 | Current EPS (TTM) | |
| 28 | 89.88% | 1.72 | -1.44 | 4.5 |
Gilead Sciences Earnings per Share Projection vs Actual
Actual Earning per Share of Gilead Sciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Gilead Sciences predict the company's earnings will be in the future. The higher the earnings per share of Gilead Sciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Gilead Sciences Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Gilead Sciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Gilead Sciences should always be considered in relation to other companies to make a more educated investment decision.Gilead Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Gilead Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-06 | 2023-12-31 | 1.76 | 1.72 | -0.04 | 2 | ||
2023-11-07 | 2023-09-30 | 1.92 | 2.29 | 0.37 | 19 | ||
2023-08-03 | 2023-06-30 | 1.64 | 1.66 | 0.02 | 1 | ||
2023-04-27 | 2023-03-31 | 1.54 | 1.37 | -0.17 | 11 | ||
2023-02-02 | 2022-12-31 | 1.5 | 1.67 | 0.17 | 11 | ||
2022-10-27 | 2022-09-30 | 1.43 | 1.9 | 0.47 | 32 | ||
2022-08-02 | 2022-06-30 | 1.52 | 1.58 | 0.06 | 3 | ||
2022-04-28 | 2022-03-31 | 1.81 | 2.12 | 0.31 | 17 | ||
2022-02-01 | 2021-12-31 | 1.59 | 0.69 | -0.9 | 56 | ||
2021-10-28 | 2021-09-30 | 1.75 | 2.65 | 0.9 | 51 | ||
2021-07-29 | 2021-06-30 | 1.73 | 1.87 | 0.14 | 8 | ||
2021-04-29 | 2021-03-31 | 2.09 | 2.08 | -0.01 | 0 | ||
2021-02-04 | 2020-12-31 | 2.15 | 2.19 | 0.04 | 1 | ||
2020-10-28 | 2020-09-30 | 1.9 | 2.11 | 0.21 | 11 | ||
2020-07-30 | 2020-06-30 | 1.45 | 1.11 | -0.34 | 23 | ||
2020-04-30 | 2020-03-31 | 1.57 | 1.68 | 0.11 | 7 | ||
2020-02-04 | 2019-12-31 | 1.67 | 1.3 | -0.37 | 22 | ||
2019-10-24 | 2019-09-30 | 1.74 | 1.75 | 0.01 | 0 | ||
2019-07-30 | 2019-06-30 | 1.72 | 1.82 | 0.1 | 5 | ||
2019-05-02 | 2019-03-31 | 1.61 | 1.76 | 0.15 | 9 | ||
2019-02-04 | 2018-12-31 | 1.7 | 1.44 | -0.26 | 15 | ||
2018-10-25 | 2018-09-30 | 1.63 | 1.84 | 0.21 | 12 | ||
2018-07-25 | 2018-06-30 | 1.56 | 1.91 | 0.35 | 22 | ||
2018-05-01 | 2018-03-31 | 1.67 | 1.48 | -0.19 | 11 | ||
2018-02-06 | 2017-12-31 | 1.67 | 1.78 | 0.11 | 6 | ||
2017-10-26 | 2017-09-30 | 2.13 | 2.27 | 0.14 | 6 | ||
2017-07-26 | 2017-06-30 | 2.15 | 2.56 | 0.41 | 19 | ||
2017-05-02 | 2017-03-31 | 2.28 | 2.23 | -0.05 | 2 | ||
2017-02-07 | 2016-12-31 | 2.61 | 2.7 | 0.09 | 3 | ||
2016-11-01 | 2016-09-30 | 2.86 | 2.75 | -0.11 | 3 | ||
2016-07-25 | 2016-06-30 | 3.02 | 3.08 | 0.06 | 1 | ||
2016-04-28 | 2016-03-31 | 3.15 | 3.03 | -0.12 | 3 | ||
2016-02-02 | 2015-12-31 | 3 | 3.32 | 0.32 | 10 | ||
2015-10-27 | 2015-09-30 | 2.87 | 3.22 | 0.35 | 12 | ||
2015-07-28 | 2015-06-30 | 2.71 | 3.15 | 0.44 | 16 | ||
2015-04-30 | 2015-03-31 | 2.32 | 2.94 | 0.62 | 26 | ||
2015-02-03 | 2014-12-31 | 2.22 | 2.43 | 0.21 | 9 | ||
2014-10-28 | 2014-09-30 | 1.92 | 2.05 | 0.13 | 6 | ||
2014-07-23 | 2014-06-30 | 1.79 | 2.36 | 0.57 | 31 | ||
2014-04-22 | 2014-03-31 | 0.91 | 1.48 | 0.57 | 62 | ||
2014-02-04 | 2013-12-31 | 0.5 | 0.55 | 0.05 | 10 | ||
2013-10-29 | 2013-09-30 | 0.48 | 0.52 | 0.04 | 8 | ||
2013-07-25 | 2013-06-30 | 0.5 | 0.5 | 0.0 | 0 | ||
2013-05-02 | 2013-03-31 | 0.5 | 0.48 | -0.02 | 4 | ||
2013-02-04 | 2012-12-31 | 0.48 | 0.5 | 0.02 | 4 | ||
2012-10-23 | 2012-09-30 | 0.47 | 0.5 | 0.03 | 6 | ||
2012-07-26 | 2012-06-30 | 0.48 | 0.5 | 0.02 | 4 | ||
2012-04-26 | 2012-03-31 | 0.47 | 0.46 | -0.01 | 2 | ||
2012-02-02 | 2011-12-31 | 0.52 | 0.49 | -0.03 | 5 | ||
2011-10-27 | 2011-09-30 | 0.5 | 0.51 | 0.01 | 2 | ||
2011-07-26 | 2011-06-30 | 0.5 | 0.5 | 0.0 | 0 | ||
2011-04-20 | 2011-03-31 | 0.48 | 0.44 | -0.04 | 8 | ||
2011-01-25 | 2010-12-31 | 0.47 | 0.48 | 0.01 | 2 | ||
2010-10-19 | 2010-09-30 | 0.44 | 0.45 | 0.01 | 2 | ||
2010-07-20 | 2010-06-30 | 0.43 | 0.43 | 0.0 | 0 | ||
2010-04-20 | 2010-03-31 | 0.48 | 0.5 | 0.02 | 4 | ||
2010-01-26 | 2009-12-31 | 0.42 | 0.47 | 0.05 | 11 | ||
2009-10-20 | 2009-09-30 | 0.34 | 0.39 | 0.05 | 14 | ||
2009-07-21 | 2009-06-30 | 0.31 | 0.35 | 0.04 | 12 | ||
2009-04-21 | 2009-03-31 | 0.3 | 0.33 | 0.03 | 10 | ||
2009-01-27 | 2008-12-31 | 0.27 | 0.3 | 0.03 | 11 | ||
2008-10-16 | 2008-09-30 | 0.25 | 0.26 | 0.01 | 4 | ||
2008-07-17 | 2008-06-30 | 0.24 | 0.23 | -0.01 | 4 | ||
2008-04-16 | 2008-03-31 | 0.24 | 0.26 | 0.02 | 8 | ||
2008-01-23 | 2007-12-31 | 0.2 | 0.21 | 0.01 | 5 | ||
2007-10-18 | 2007-09-30 | 0.2 | 0.21 | 0.01 | 5 | ||
2007-07-19 | 2007-06-30 | 0.2 | 0.21 | 0.01 | 5 | ||
2007-04-18 | 2007-03-31 | 0.2 | 0.21 | 0.01 | 5 | ||
2007-01-31 | 2006-12-31 | 0.17 | 0.2 | 0.03 | 17 | ||
2006-10-18 | 2006-09-30 | 0.14 | 0.16 | 0.02 | 14 | ||
2006-07-20 | 2006-06-30 | 0.13 | 0.14 | 0.01 | 7 | ||
2006-04-18 | 2006-03-31 | 0.13 | 0.14 | 0.01 | 7 | ||
2006-01-30 | 2005-12-31 | 0.13 | 0.14 | 0.01 | 7 | ||
2005-10-18 | 2005-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2005-07-19 | 2005-06-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2005-04-19 | 2005-03-31 | 0.07 | 0.09 | 0.02 | 28 | ||
2005-01-27 | 2004-12-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2004-10-21 | 2004-09-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2004-07-29 | 2004-06-30 | 0.04 | 0.06 | 0.02 | 50 | ||
2004-04-22 | 2004-03-31 | 0.04 | 0.06 | 0.02 | 50 | ||
2004-01-29 | 2003-12-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2003-10-28 | 2003-09-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2003-07-31 | 2003-06-30 | 0.06 | 0.06 | 0.0 | 0 | ||
2003-04-23 | 2003-03-31 | 0.02 | 0.03 | 0.01 | 50 | ||
2003-01-30 | 2002-12-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2002-10-31 | 2002-09-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2002-07-24 | 2002-06-30 | 0.01 | 0.01 | 0.0 | 0 | ||
2002-04-30 | 2002-03-31 | -0.01 | -0.0025 | 0.0075 | 75 | ||
2002-01-31 | 2001-12-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2001-10-25 | 2001-09-30 | -0.02 | -0.02 | 0.0 | 0 | ||
2001-07-26 | 2001-06-30 | -0.01 | -0.02 | -0.01 | 100 | ||
2001-04-26 | 2001-03-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2001-01-25 | 2000-12-31 | -0.01 | -0.01 | 0.0 | 0 | ||
2000-10-26 | 2000-09-30 | -0.01 | -0.01 | 0.0 | 0 | ||
2000-07-27 | 2000-06-30 | -0.01 | -0.0029 | 0.0071 | 71 | ||
2000-04-27 | 2000-03-31 | -0.01 | -0.0041 | 0.0059 | 59 | ||
2000-01-27 | 1999-12-31 | -0.01 | -0.01 | 0.0 | 0 | ||
1999-10-27 | 1999-09-30 | -0.01 | -0.01 | 0.0 | 0 | ||
1999-07-29 | 1999-06-30 | -0.01 | -0.01 | 0.0 | 0 | ||
1999-04-29 | 1999-03-31 | -0.02 | -0.02 | 0.0 | 0 | ||
1999-01-27 | 1998-12-31 | -0.02 | -0.02 | 0.0 | 0 | ||
1998-10-28 | 1998-09-30 | -0.02 | -0.02 | 0.0 | 0 | ||
1998-07-30 | 1998-06-30 | -0.02 | -0.02 | 0.0 | 0 | ||
1998-04-30 | 1998-03-31 | -0.02 | -0.01 | 0.01 | 50 | ||
1998-01-29 | 1997-12-31 | -0.01 | -0.01 | 0.0 | 0 | ||
1997-10-30 | 1997-09-30 | -0.01 | -0.01 | 0.0 | 0 | ||
null | null | null | null | null | 0 | ||
1997-04-25 | 1997-03-31 | 0 | -0.01 | -0.01 | 0 | ||
1997-01-31 | 1996-12-31 | -0.01 | -0.01 | 0.0 | 0 | ||
1996-10-25 | 1996-09-30 | 0 | 0.01 | 0.01 | 0 | ||
1996-07-26 | 1996-06-30 | -0.01 | -0.01 | 0.0 | 0 | ||
1996-04-26 | 1996-03-31 | -0.02 | -0.01 | 0.01 | 50 | ||
1996-01-22 | 1995-12-31 | -0.01 | -0.01 | 0.0 | 0 | ||
1995-10-26 | 1995-09-30 | -0.01 | -0.01 | 0.0 | 0 |
About Gilead Sciences Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Gilead Sciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Gilead Sciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Gilead Sciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | 16.3 B | 17.1 B | |
| Retained Earnings Total Equity | 18 B | 12.7 B | |
| Earnings Yield | 0.06 | 0.06 | |
| Price Earnings Ratio | 17.85 | 20.47 | |
| Price Earnings To Growth Ratio | 0.74 | 0.78 |
Gilead Sciences Investors Sentiment
The influence of Gilead Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Gilead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Gilead Sciences' public news can be used to forecast risks associated with an investment in Gilead. The trend in average sentiment can be used to explain how an investor holding Gilead can time the market purely based on public headlines and social activities around Gilead Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gilead Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gilead Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Gilead Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Gilead Sciences.
Gilead Sciences Implied Volatility | 60.6 |
Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gilead Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gilead Sciences' short interest history, or implied volatility extrapolated from Gilead Sciences options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3 | Earnings Share 4.5 | Revenue Per Share 21.728 | Quarterly Revenue Growth (0.04) |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.